Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Natera (NTRA) Drug Pipeline

1,368 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Ctdna-Guided Treatment StrategyBreast Neoplasms, Carcinoma, Ductal, Breast, Receptors, Estrogen (For Er-Positive Requirement)Phase IINot Yet RecruitingSignatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerSep 24, 2025
Atezolizumab, SignateraMuscle-Invasive Bladder CancerPhase IIIActive Not RecruitingA Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following CystectomyDec 01, 2020―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Natera Inc. (NTRA) have in its pipeline
Natera NTRA is currently developing the following drugs: Ctdna-Guided Treatment Strategy, Atezolizumab, Signatera. These drug candidates are in various stages of clinical development as the company works toward FDA approval.